Cathy Gwin
Senior Director, Communications
News
Media Contact
NTI Endorses Biosecurity Modernization and Innovation Act of 2026
NTI endorses the bipartisan Biosecurity Modernization and Innovation Act of 2026, led by Senators Tom Cotton (R-AR) and Amy Klobuchar (D-MN). This bill creates an important opportunity to incentivize a safe and secure U.S. bioeconomy through strengthened biosecurity policy.
NTI President and CEO Christine Wormuth on the Expiration of the New START Treaty
New START, the last remaining arms control treaty capping U.S. and Russian nuclear arsenals, expires on February 5. This marks the beginning of a dangerous new era. For the first time in several decades, there will be no limits on nuclear weapons, less visibility into Russian nuclear weapons activities, and fewer tools to manage a crisis between the world’s two largest nuclear powers.
Nuclear Scaling Initiative secures $3.5M to advance U.S. reactor orderbook
Funding from the Bezos Earth Fund will support the creation of an orderbook for new nuclear reactor builds in the United States.
New NTI Framework Tackles Misuse Risks in AIxBio Tools
New NTI | bio paper calls on tool developers and other AIxBio stakeholders to implement a managed access approach—allowing only validated users to access those biological AI models that contribute to biosecurity risks—to help reduce the risk that such tools will be deliberately misused to cause harm.
Americans Across Party Lines Want the U.S. to Keep Nuclear Limits with Russia, New Poll Finds
As the last remaining U.S.-Russia nuclear limitations treaty expires on Feb. 5, an overwhelming majority of Americans (91 percent) say the United States should negotiate a new agreement with Russia to either maintain current limits on nuclear weapons or further reduce both countries’ arsenals.
B-roll North Korean Nuclear Test
B-Roll IRAN Natanz Enrichment Complex
B-roll Rattehalli Materials Plant - India
Stay Informed
Sign up for our newsletter to get the latest on nuclear and biological threats.
